KEY vs VIR · P/E 13, rev $7.51B vs rev $74.2M
KeyCorp (KEY) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
KeyCorp (KEY) is a banks - regional company listed on US.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Latest reported VIR revenue for 2024-12-31 was $74.2M. Net income was -$522.0M. Revenue was down 13.9% from 2023-12-31 to 2024-12-31. VIR currently screens at market cap $1.45B.
KEY currently screens at market cap $22.64B and trailing P/E 12.8. VIR currently screens at market cap $1.45B.
Not investment advice. Open the KEY and VIR stock pages for the full models.
Not investment advice.